1. Home
  2. SRDX vs LXFR Comparison

SRDX vs LXFR Comparison

Compare SRDX & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • LXFR
  • Stock Information
  • Founded
  • SRDX 1979
  • LXFR 1898
  • Country
  • SRDX United States
  • LXFR United States
  • Employees
  • SRDX N/A
  • LXFR N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • LXFR Major Chemicals
  • Sector
  • SRDX Health Care
  • LXFR Industrials
  • Exchange
  • SRDX Nasdaq
  • LXFR Nasdaq
  • Market Cap
  • SRDX 402.2M
  • LXFR 335.4M
  • IPO Year
  • SRDX 1998
  • LXFR 2012
  • Fundamental
  • Price
  • SRDX $27.75
  • LXFR $13.28
  • Analyst Decision
  • SRDX Buy
  • LXFR
  • Analyst Count
  • SRDX 3
  • LXFR 0
  • Target Price
  • SRDX $43.00
  • LXFR N/A
  • AVG Volume (30 Days)
  • SRDX 113.5K
  • LXFR 87.4K
  • Earning Date
  • SRDX 11-05-2025
  • LXFR 10-28-2025
  • Dividend Yield
  • SRDX N/A
  • LXFR 3.94%
  • EPS Growth
  • SRDX N/A
  • LXFR N/A
  • EPS
  • SRDX N/A
  • LXFR 0.90
  • Revenue
  • SRDX $120,801,000.00
  • LXFR $403,800,000.00
  • Revenue This Year
  • SRDX N/A
  • LXFR $3.12
  • Revenue Next Year
  • SRDX $3.38
  • LXFR $3.31
  • P/E Ratio
  • SRDX N/A
  • LXFR $14.68
  • Revenue Growth
  • SRDX N/A
  • LXFR 5.60
  • 52 Week Low
  • SRDX $26.00
  • LXFR $9.41
  • 52 Week High
  • SRDX $40.39
  • LXFR $15.64
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 29.38
  • LXFR 49.00
  • Support Level
  • SRDX $26.82
  • LXFR $12.78
  • Resistance Level
  • SRDX $28.69
  • LXFR $13.74
  • Average True Range (ATR)
  • SRDX 0.60
  • LXFR 0.47
  • MACD
  • SRDX 0.12
  • LXFR -0.04
  • Stochastic Oscillator
  • SRDX 39.74
  • LXFR 47.02

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

Share on Social Networks: